Point/Counterpoint: Early Detection of Prostate Cancer: Do the Benefits Outweigh the Consequences?

Restricted access

Few clinical issues have polarized the oncology community as much as screening for prostate cancer, with advocates of prostate-specific antigen (PSA) testing vocal on one side and skeptics just as vocal on the other. At the NCCN 19th Annual Conference, Dr. Peter R. Carroll and Dr. Andrew J. Vickers tackled the controversy surrounding early detection of prostate cancer, focusing attention on the randomized trial results at the heart of the matter; over-detection (the Achilles’ heel of screening); and the rationale behind the new, streamlined 2014 NCCN Clinical Practice Guidelines in Oncology (NCCN Guidelines) for Prostate Cancer Early Detection, which emphasize selective early detection and treatment and are tightly aligned with the NCCN Guidelines for Prostate Cancer.

Correspondence: Peter R. Carroll, MD, MPH, UCSF Medical Center, 1600 Divisadero Street, Bldg A-630, Box 1695, San Francisco, CA 94143-1695. E-mail: PCarroll@urology.ucsf.eduCorrespondence: Andrew J. Vickers, PhD, Memorial Sloan-Kettering Cancer Center, 307 E 63rd Street, 2nd Floor, New York, NY 10065. E-mail: vickersa@mskcc.org
  • 1.

    Andriole GL, Crawford ED, Grubb RL 3rd. Mortality results from a randomized prostate-cancer screening trial. N Engl J Med 2009;360:13101319.

  • 2.

    Schröder FH, Hugosson J, Roobol MJ. Prostate-cancer mortality at 11 years of follow-up. N Engl J Med 2012;366:981990.

  • 3.

    Moyer VA. Screening for prostate cancer: U.S. Preventive Services Task Force recommendation statement. Ann Intern Med 2012;157:120134.

    • Search Google Scholar
    • Export Citation
  • 4.

    Bill-Axelson A, Holmberg L, Garmo H. Radical prostatectomy or watchful waiting in early prostate cancer. N Engl J Med 2014;370:932942.

  • 5.

    Hugosson J, Carlsson S, Aus G. Mortality results from the Göteborg randomized population-based prostate-cancer screening trial. Lancet Oncol 2010;11:725732.

    • Search Google Scholar
    • Export Citation
  • 6.

    Carroll PR, Whitson JM, Cooperberg MR. Serum prostate-specific antigen for the early detection of prostate cancer: always, never, or only sometimes? J Clin Oncol 2011;29:345347.

    • Search Google Scholar
    • Export Citation
  • 7.

    Vickers AJ, Sjoberg DD, Ulmert D. Empirical estimates of prostate cancer overdiagnosis by age and prostate-specific antigen. BMC Med 2014;12:26.

    • Search Google Scholar
    • Export Citation
  • 8.

    Savage CJ, Vickers AJ. Low annual caseloads of United States surgeons conducting radical prostatectomy. J Urol 2009;182:26772679.

  • 9.

    Cooperberg MR, Carroll PR, Klotz L. Active surveillance for prostate cancer: progress and promise. J Clin Oncol 2011;29:36693676.

All Time Past Year Past 30 Days
Abstract Views 0 0 0
Full Text Views 153 118 8
PDF Downloads 22 18 2
EPUB Downloads 0 0 0